25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

INDRAMEDCO (INDRAPRASTHA MEDICAL CORP.LTD.) Stock Analysis
Buy, Hold or Sell?

Let's analyze INDRAPRASTHA MEDICAL CORP.LTD. together

I guess you are interested in INDRAPRASTHA MEDICAL CORP.LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – INDRAPRASTHA MEDICAL CORP.LTD.’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – INDRAPRASTHA MEDICAL CORP.LTD.’s Price Targets

I'm going to help you getting a better view of INDRAPRASTHA MEDICAL CORP.LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about INDRAPRASTHA MEDICAL CORP.LTD.

I send you an email if I find something interesting about INDRAPRASTHA MEDICAL CORP.LTD..

1. Quick Overview

1.1. Quick analysis of INDRAPRASTHA MEDICAL CORP.LTD. (30 sec.)










1.2. What can you expect buying and holding a share of INDRAPRASTHA MEDICAL CORP.LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.21
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR65.09
Expected worth in 1 year
INR116.98
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR69.66
Return On Investment
14.3%

For what price can you sell your share?

Current Price per Share
INR488.50
Expected price per share
INR452.00 - INR571.95
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of INDRAPRASTHA MEDICAL CORP.LTD. (5 min.)




Live pricePrice per Share (EOD)
INR488.50
Intrinsic Value Per Share
INR124.59 - INR237.06
Total Value Per Share
INR189.68 - INR302.14

2.2. Growth of INDRAPRASTHA MEDICAL CORP.LTD. (5 min.)




Is INDRAPRASTHA MEDICAL CORP.LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$69.8m$55.8m$13.9m19.9%

How much money is INDRAPRASTHA MEDICAL CORP.LTD. making?

Current yearPrevious yearGrowGrow %
Making money$18.8m$14.5m$4.3m23.0%
Net Profit Margin11.9%10.0%--

How much money comes from the company's main activities?

2.3. Financial Health of INDRAPRASTHA MEDICAL CORP.LTD. (5 min.)




2.4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#119 / 170

Most Revenue
#85 / 170

Most Profit
#49 / 170
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of INDRAPRASTHA MEDICAL CORP.LTD.?

Welcome investor! INDRAPRASTHA MEDICAL CORP.LTD.'s management wants to use your money to grow the business. In return you get a share of INDRAPRASTHA MEDICAL CORP.LTD..

First you should know what it really means to hold a share of INDRAPRASTHA MEDICAL CORP.LTD.. And how you can make/lose money.

Speculation

The Price per Share of INDRAPRASTHA MEDICAL CORP.LTD. is INR488.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of INDRAPRASTHA MEDICAL CORP.LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in INDRAPRASTHA MEDICAL CORP.LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR65.09. Based on the TTM, the Book Value Change Per Share is INR12.97 per quarter. Based on the YOY, the Book Value Change Per Share is INR10.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR4.44 per quarter.
Based on historical numbers we can estimate the returns while holding a share of INDRAPRASTHA MEDICAL CORP.LTD..

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.210.0%0.210.0%0.160.0%0.160.0%0.110.0%0.090.0%
Usd Book Value Change Per Share0.150.0%0.150.0%0.130.0%0.120.0%0.080.0%0.110.0%
Usd Dividend Per Share0.050.0%0.050.0%0.040.0%0.040.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.200.0%0.200.0%0.160.0%0.150.0%0.110.0%0.130.0%
Usd Price Per Share4.52-4.52-2.01-2.48-1.75-1.37-
Price to Earnings Ratio21.98-21.98-12.70-14.32-52.71-40.44-
Price-to-Total Gains Ratio22.17-22.17-12.51-14.65-29.78-22.53-
Price to Book Ratio5.93-5.93-3.30-3.70-2.91-2.45-
Price-to-Total Gains Ratio22.17-22.17-12.51-14.65-29.78-22.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.71545
Number of shares174
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.02
Usd Book Value Change Per Share0.150.08
Usd Total Gains Per Share0.200.11
Gains per Quarter (174 shares)35.4518.68
Gains per Year (174 shares)141.8274.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
136106132165865
27221127433117140
310931741649175215
414542355865234290
518152870081292365
621763484298351440
7253739984114409515
82898451126130467590
93269511268146526665
1036210561410163584740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of INDRAPRASTHA MEDICAL CORP.LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--12.97212.9720%10.724+21%9.863+32%7.175+81%9.298+40%
Book Value Per Share--65.08865.0880%52.116+25%52.865+23%44.770+45%39.954+63%
Current Ratio--2.4122.4120%1.862+30%1.998+21%1.780+36%1.572+53%
Debt To Asset Ratio--0.2990.2990%0.339-12%0.318-6%0.324-8%0.349-14%
Debt To Equity Ratio--0.4270.4270%0.514-17%0.468-9%0.481-11%0.545-22%
Dividend Per Share--4.4434.4430%3.004+48%3.313+34%1.999+122%1.957+127%
Enterprise Value--32840961650.00032840961650.0000%13290037750.000+147%17166613896.667+91%11766170458.000+179%8837652884.286+272%
Eps--17.56117.5610%13.522+30%13.494+30%9.426+86%7.855+124%
Ev To Sales Ratio--2.4212.4210%1.068+127%1.326+83%1.000+142%0.770+214%
Free Cash Flow Per Share--13.13613.1360%14.264-8%12.765+3%8.723+51%7.845+67%
Free Cash Flow To Equity Per Share--13.13613.1360%14.264-8%12.765+3%8.581+53%6.389+106%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--237.056----------
Intrinsic Value_10Y_min--124.588----------
Intrinsic Value_1Y_max--15.169----------
Intrinsic Value_1Y_min--9.770----------
Intrinsic Value_3Y_max--52.119----------
Intrinsic Value_3Y_min--31.880----------
Intrinsic Value_5Y_max--96.959----------
Intrinsic Value_5Y_min--56.588----------
Market Cap44782260500.000+21%35390361650.00035390361650.0000%15744837750.000+125%19420313896.667+82%13709330458.000+158%10739230027.143+230%
Net Profit Margin--0.1190.1190%0.100+19%0.099+20%0.074+61%0.066+80%
Operating Margin----0%-0%0.034-100%0.043-100%0.050-100%
Operating Ratio--1.4891.4890%1.512-2%1.444+3%1.416+5%1.405+6%
Pb Ratio7.505+21%5.9315.9310%3.296+80%3.702+60%2.912+104%2.451+142%
Pe Ratio27.817+21%21.98321.9830%12.702+73%14.319+54%52.715-58%40.440-46%
Price Per Share488.500+21%386.050386.0500%171.750+125%211.843+82%149.546+158%117.147+230%
Price To Free Cash Flow Ratio37.188+21%29.38929.3890%12.041+144%16.188+82%26.486+11%20.760+42%
Price To Total Gains Ratio28.050+21%22.16722.1670%12.511+77%14.650+51%29.780-26%22.533-2%
Quick Ratio--1.9311.9310%1.361+42%1.487+30%1.171+65%1.037+86%
Return On Assets--0.1890.1890%0.171+10%0.172+10%0.130+46%0.116+63%
Return On Equity--0.2700.2700%0.259+4%0.252+7%0.189+43%0.175+54%
Total Gains Per Share--17.41517.4150%13.728+27%13.175+32%9.174+90%11.255+55%
Usd Book Value--69811560.00069811560.0000%55897920.000+25%56701710.000+23%48018812.400+45%42854124.857+63%
Usd Book Value Change Per Share--0.1520.1520%0.125+21%0.115+32%0.084+81%0.109+40%
Usd Book Value Per Share--0.7620.7620%0.610+25%0.619+23%0.524+45%0.467+63%
Usd Dividend Per Share--0.0520.0520%0.035+48%0.039+34%0.023+122%0.023+127%
Usd Enterprise Value--384239251.305384239251.3050%155493441.675+147%200849382.591+91%137664194.359+179%103400538.746+272%
Usd Eps--0.2050.2050%0.158+30%0.158+30%0.110+86%0.092+124%
Usd Free Cash Flow--14089140.00014089140.0000%15298920.000-8%13691730.000+3%9355671.000+51%8414623.286+67%
Usd Free Cash Flow Per Share--0.1540.1540%0.167-8%0.149+3%0.102+51%0.092+67%
Usd Free Cash Flow To Equity Per Share--0.1540.1540%0.167-8%0.149+3%0.100+53%0.075+106%
Usd Market Cap523952447.850+21%414067231.305414067231.3050%184214601.675+125%227217672.591+82%160399166.359+158%125648991.318+230%
Usd Price Per Share5.715+21%4.5174.5170%2.009+125%2.479+82%1.750+158%1.371+230%
Usd Profit--18835830.00018835830.0000%14503320.000+30%14472900.000+30%10109946.600+86%8425437.429+124%
Usd Revenue--158694120.000158694120.0000%145629900.000+9%144289470.000+10%120695140.800+31%112230210.857+41%
Usd Total Gains Per Share--0.2040.2040%0.161+27%0.154+32%0.107+90%0.132+55%
 EOD+4 -4MRQTTM+0 -0YOY+28 -93Y+32 -65Y+32 -610Y+32 -6

3.3 Fundamental Score

Let's check the fundamental score of INDRAPRASTHA MEDICAL CORP.LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.817
Price to Book Ratio (EOD)Between0-17.505
Net Profit Margin (MRQ)Greater than00.119
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.931
Current Ratio (MRQ)Greater than12.412
Debt to Asset Ratio (MRQ)Less than10.299
Debt to Equity Ratio (MRQ)Less than10.427
Return on Equity (MRQ)Greater than0.150.270
Return on Assets (MRQ)Greater than0.050.189
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of INDRAPRASTHA MEDICAL CORP.LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.275
Ma 20Greater thanMa 50450.665
Ma 50Greater thanMa 100431.738
Ma 100Greater thanMa 200408.109
OpenGreater thanClose494.750
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About INDRAPRASTHA MEDICAL CORP.LTD.

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, and sleep medicine. The company was founded in 1983 and is based in New Delhi, India.

Fundamental data was last updated by Penke on 2025-06-21 22:02:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ INDRAPRASTHA MEDICAL CORP.LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compareΒ INDRAPRASTHA MEDICAL CORP.LTD. to theΒ Medical Care Facilities industry mean.
  • A Net Profit Margin of 11.9%Β means thatΒ ₹0.12 for each ₹1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 11.9%. The company is making a huge profit. +2
  • The TTM is 11.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.9%TTM11.9%0.0%
TTM11.9%YOY10.0%+1.9%
TTM11.9%5Y7.4%+4.5%
5Y7.4%10Y6.6%+0.8%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ11.9%3.8%+8.1%
TTM11.9%3.4%+8.5%
YOY10.0%2.6%+7.4%
3Y9.9%2.7%+7.2%
5Y7.4%3.2%+4.2%
10Y6.6%3.8%+2.8%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ INDRAPRASTHA MEDICAL CORP.LTD. is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ INDRAPRASTHA MEDICAL CORP.LTD. to theΒ Medical Care Facilities industry mean.
  • 18.9% Return on Assets means thatΒ INDRAPRASTHA MEDICAL CORP.LTD. generatedΒ ₹0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 18.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 18.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.9%TTM18.9%0.0%
TTM18.9%YOY17.1%+1.8%
TTM18.9%5Y13.0%+5.9%
5Y13.0%10Y11.6%+1.4%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ18.9%1.0%+17.9%
TTM18.9%0.9%+18.0%
YOY17.1%1.2%+15.9%
3Y17.2%0.9%+16.3%
5Y13.0%0.9%+12.1%
10Y11.6%1.0%+10.6%
4.3.1.3. Return on Equity

Shows how efficient INDRAPRASTHA MEDICAL CORP.LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ INDRAPRASTHA MEDICAL CORP.LTD. to theΒ Medical Care Facilities industry mean.
  • 27.0% Return on Equity means INDRAPRASTHA MEDICAL CORP.LTD. generated ₹0.27Β for eachΒ ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 27.0%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 27.0%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ27.0%TTM27.0%0.0%
TTM27.0%YOY25.9%+1.0%
TTM27.0%5Y18.9%+8.1%
5Y18.9%10Y17.5%+1.4%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ27.0%2.7%+24.3%
TTM27.0%2.4%+24.6%
YOY25.9%3.0%+22.9%
3Y25.2%2.5%+22.7%
5Y18.9%2.4%+16.5%
10Y17.5%2.7%+14.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of INDRAPRASTHA MEDICAL CORP.LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient INDRAPRASTHA MEDICAL CORP.LTD. is operatingΒ .

  • Measures how much profit INDRAPRASTHA MEDICAL CORP.LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ INDRAPRASTHA MEDICAL CORP.LTD. to theΒ Medical Care Facilities industry mean.
  • An Operating Margin of 0.0%Β means the company generated ₹0.00 Β for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y4.3%-4.3%
5Y4.3%10Y5.0%-0.7%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-6.2%
TTM-6.6%-6.6%
YOY-6.2%-6.2%
3Y3.4%5.6%-2.2%
5Y4.3%6.4%-2.1%
10Y5.0%7.5%-2.5%
4.3.2.2. Operating Ratio

Measures how efficient INDRAPRASTHA MEDICAL CORP.LTD. is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Care Facilities industry mean).
  • An Operation Ratio of 1.49 means that the operating costs are ₹1.49 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 1.489. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.489. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.489TTM1.4890.000
TTM1.489YOY1.512-0.023
TTM1.4895Y1.416+0.072
5Y1.41610Y1.405+0.011
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4891.266+0.223
TTM1.4891.103+0.386
YOY1.5120.999+0.513
3Y1.4441.061+0.383
5Y1.4161.014+0.402
10Y1.4050.998+0.407
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of INDRAPRASTHA MEDICAL CORP.LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if INDRAPRASTHA MEDICAL CORP.LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Care Facilities industry mean).
  • A Current Ratio of 2.41Β means the company has ₹2.41 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 2.412. The company is able to pay all its short-term debts. +1
  • The TTM is 2.412. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.412TTM2.4120.000
TTM2.412YOY1.862+0.551
TTM2.4125Y1.780+0.633
5Y1.78010Y1.572+0.208
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4121.283+1.129
TTM2.4121.260+1.152
YOY1.8621.320+0.542
3Y1.9981.346+0.652
5Y1.7801.400+0.380
10Y1.5721.423+0.149
4.4.3.2. Quick Ratio

Measures if INDRAPRASTHA MEDICAL CORP.LTD. is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ INDRAPRASTHA MEDICAL CORP.LTD. to theΒ Medical Care Facilities industry mean.
  • A Quick Ratio of 1.93Β means the company can pay off ₹1.93 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 1.931. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.931. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.931TTM1.9310.000
TTM1.931YOY1.361+0.570
TTM1.9315Y1.171+0.759
5Y1.17110Y1.037+0.134
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9310.642+1.289
TTM1.9310.773+1.158
YOY1.3610.874+0.487
3Y1.4870.950+0.537
5Y1.1711.084+0.087
10Y1.0371.173-0.136
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of INDRAPRASTHA MEDICAL CORP.LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of INDRAPRASTHA MEDICAL CORP.LTD.Β assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ INDRAPRASTHA MEDICAL CORP.LTD. to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.30Β means that INDRAPRASTHA MEDICAL CORP.LTD. assets areΒ financed with 29.9% credit (debt) and the remaining percentage (100% - 29.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 0.299. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.299. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.299TTM0.2990.000
TTM0.299YOY0.339-0.040
TTM0.2995Y0.324-0.024
5Y0.32410Y0.349-0.025
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2990.505-0.206
TTM0.2990.501-0.202
YOY0.3390.487-0.148
3Y0.3180.492-0.174
5Y0.3240.519-0.195
10Y0.3490.531-0.182
4.5.4.2. Debt to Equity Ratio

Measures ifΒ INDRAPRASTHA MEDICAL CORP.LTD. is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ INDRAPRASTHA MEDICAL CORP.LTD. to theΒ Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 42.7% means that company has ₹0.43 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The MRQ is 0.427. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.427. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.427TTM0.4270.000
TTM0.427YOY0.514-0.087
TTM0.4275Y0.481-0.054
5Y0.48110Y0.545-0.064
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4270.968-0.541
TTM0.4270.934-0.507
YOY0.5140.927-0.413
3Y0.4680.968-0.500
5Y0.4811.096-0.615
10Y0.5451.160-0.615
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every ₹1 in earnings INDRAPRASTHA MEDICAL CORP.LTD. generates.

  • Above 15 is considered overpriced butΒ always compareΒ INDRAPRASTHA MEDICAL CORP.LTD. to theΒ Medical Care Facilities industry mean.
  • A PE ratio of 21.98 means the investor is paying ₹21.98Β for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The EOD is 27.817. Based on the earnings, the company is overpriced. -1
  • The MRQ is 21.983. Based on the earnings, the company is fair priced.
  • The TTM is 21.983. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD27.817MRQ21.983+5.834
MRQ21.983TTM21.9830.000
TTM21.983YOY12.702+9.281
TTM21.9835Y52.715-30.732
5Y52.71510Y40.440+12.275
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD27.81714.803+13.014
MRQ21.98315.772+6.211
TTM21.98313.534+8.449
YOY12.70215.376-2.674
3Y14.31915.549-1.230
5Y52.71516.300+36.415
10Y40.44021.057+19.383
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The EOD is 37.188. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 29.389. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 29.389. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD37.188MRQ29.389+7.799
MRQ29.389TTM29.3890.000
TTM29.389YOY12.041+17.348
TTM29.3895Y26.486+2.903
5Y26.48610Y20.760+5.726
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD37.1887.909+29.279
MRQ29.3897.601+21.788
TTM29.3896.835+22.554
YOY12.0417.737+4.304
3Y16.1887.176+9.012
5Y26.4867.207+19.279
10Y20.7608.755+12.005
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ INDRAPRASTHA MEDICAL CORP.LTD. is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 5.93 means the investor is paying ₹5.93Β for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of INDRAPRASTHA MEDICAL CORP.LTD.:

  • The EOD is 7.505. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.931. Based on the equity, the company is overpriced. -1
  • The TTM is 5.931. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.505MRQ5.931+1.574
MRQ5.931TTM5.9310.000
TTM5.931YOY3.296+2.636
TTM5.9315Y2.912+3.020
5Y2.91210Y2.451+0.460
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD7.5051.733+5.772
MRQ5.9311.725+4.206
TTM5.9311.826+4.105
YOY3.2962.142+1.154
3Y3.7022.082+1.620
5Y2.9122.472+0.440
10Y2.4512.877-0.426
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets8,516,200
Total Liabilities2,549,400
Total Stockholder Equity5,966,800
 As reported
Total Liabilities 2,549,400
Total Stockholder Equity+ 5,966,800
Total Assets = 8,516,200

Assets

Total Assets8,516,200
Total Current Assets4,311,300
Long-term Assets4,204,900
Total Current Assets
Cash And Cash Equivalents 614,800
Short-term Investments 2,695,900
Net Receivables 754,500
Inventory 69,900
Other Current Assets 166,000
Total Current Assets  (as reported)4,311,300
Total Current Assets  (calculated)4,301,100
+/- 10,200
Long-term Assets
Property Plant Equipment 3,599,900
Long-term Assets Other 27,900
Long-term Assets  (as reported)4,204,900
Long-term Assets  (calculated)3,627,800
+/- 577,100

Liabilities & Shareholders' Equity

Total Current Liabilities1,787,100
Long-term Liabilities762,300
Total Stockholder Equity5,966,800
Total Current Liabilities
Accounts payable 1,225,400
Other Current Liabilities 210,300
Total Current Liabilities  (as reported)1,787,100
Total Current Liabilities  (calculated)1,435,700
+/- 351,400
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt327,600
Long-term Liabilities  (as reported)762,300
Long-term Liabilities  (calculated)327,600
+/- 434,700
Total Stockholder Equity
Total Stockholder Equity (as reported)5,966,800
Total Stockholder Equity (calculated)0
+/- 5,966,800
Other
Capital Stock916,700
Common Stock Shares Outstanding 91,673
Net Invested Capital 5,966,800
Net Working Capital 2,524,200
Property Plant and Equipment Gross 3,599,900



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
4,223,680
4,489,920
4,319,560
4,617,100
5,551,400
7,232,400
8,516,200
8,516,2007,232,4005,551,4004,617,1004,319,5604,489,9204,223,68000
   > Total Current Assets 
1,579,401
1,329,020
1,355,540
1,414,720
1,414,300
1,574,300
2,230,800
3,079,800
4,311,300
4,311,3003,079,8002,230,8001,574,3001,414,3001,414,7201,355,5401,329,0201,579,401
       Cash And Cash Equivalents 
0
0
168,180
203,320
249,210
417,400
522,600
616,000
614,800
614,800616,000522,600417,400249,210203,320168,18000
       Short-term Investments 
0
0
53,240
49,070
46,890
290,500
832,700
1,667,200
2,695,900
2,695,9001,667,200832,700290,50046,89049,07053,24000
       Net Receivables 
1,282,962
1,049,350
940,510
791,520
673,900
433,500
682,400
584,000
754,500
754,500584,000682,400433,500673,900791,520940,5101,049,3501,282,962
       Inventory 
99,487
91,240
83,160
120,660
87,400
99,900
84,500
75,300
69,900
69,90075,30084,50099,90087,400120,66083,16091,24099,487
       Other Current Assets 
68,739
61,780
60,380
46,500
29,100
29,100
33,200
111,500
166,000
166,000111,50033,20029,10029,10046,50060,38061,78068,739
   > Long-term Assets 
0
0
2,868,140
3,075,200
2,905,310
3,042,800
3,320,600
4,152,600
4,204,900
4,204,9004,152,6003,320,6003,042,8002,905,3103,075,2002,868,14000
       Property Plant Equipment 
2,938,931
2,927,740
2,809,240
3,012,740
2,832,910
2,751,500
2,766,200
3,488,600
3,599,900
3,599,9003,488,6002,766,2002,751,5002,832,9103,012,7402,809,2402,927,7402,938,931
       Intangible Assets 
0
0
4,310
14,020
33,820
17,100
9,600
10,500
0
010,5009,60017,10033,82014,0204,31000
       Long-term Assets Other 
0
0
0
0
20,270
25,800
70,600
51,700
27,900
27,90051,70070,60025,80020,2700000
> Total Liabilities 
0
0
1,783,320
1,811,920
1,592,000
1,362,700
1,756,900
2,454,800
2,549,400
2,549,4002,454,8001,756,9001,362,7001,592,0001,811,9201,783,32000
   > Total Current Liabilities 
1,857,422
1,384,290
1,240,950
1,396,050
1,159,000
935,000
1,296,300
1,654,200
1,787,100
1,787,1001,654,2001,296,300935,0001,159,0001,396,0501,240,9501,384,2901,857,422
       Short Long Term Debt 
0
0
62,900
39,750
0
0
0
0
0
0000039,75062,90000
       Accounts payable 
240,845
303,070
375,690
433,090
397,900
390,900
588,700
1,396,000
1,225,400
1,225,4001,396,000588,700390,900397,900433,090375,690303,070240,845
       Other Current Liabilities 
135,634
117,830
163,270
143,470
88,900
100,900
147,900
62,300
210,300
210,30062,300147,900100,90088,900143,470163,270117,830135,634
   > Long-term Liabilities 
0
0
542,370
415,870
432,940
427,700
460,600
800,600
762,300
762,300800,600460,600427,700432,940415,870542,37000
       Capital Lease Obligations Min Short Term Debt
0
0
0
99,110
78,180
53,100
24,800
339,500
327,600
327,600339,50024,80053,10078,18099,110000
       Long-term Liabilities Other 
0
0
0
0
0
17,900
16,600
8,800
0
08,80016,60017,90000000
> Total Stockholder Equity
0
0
2,440,360
2,678,000
2,727,560
3,254,400
3,794,500
4,777,600
5,966,800
5,966,8004,777,6003,794,5003,254,4002,727,5602,678,0002,440,36000
   Common Stock
916,730
916,730
916,730
916,730
916,700
916,700
0
0
0
000916,700916,700916,730916,730916,730916,730
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
4,078
6,500
5,380
-15,100
11,200
-48,100
-140,300
0
0
00-140,300-48,10011,200-15,1005,3806,5004,078



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue13,563,600
Cost of Revenue-8,627,400
Gross Profit4,936,2004,936,200
 
Operating Income (+$)
Gross Profit4,936,200
Operating Expense-11,564,200
Operating Income1,999,400-6,628,000
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense11,564,2000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-62,700
Other Finance Cost-0
Net Interest Income-62,700
 
Pretax Income (+$)
Operating Income1,999,400
Net Interest Income-62,700
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,163,2001,999,400
EBIT - interestExpense = -62,700
1,609,900
1,672,600
Interest Expense62,700
Earnings Before Interest and Taxes (EBIT)02,225,900
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,163,200
Tax Provision-553,300
Net Income From Continuing Ops1,609,9001,609,900
Net Income1,609,900
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net062,700
 

Technical Analysis of INDRAPRASTHA MEDICAL CORP.LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of INDRAPRASTHA MEDICAL CORP.LTD.. The general trend of INDRAPRASTHA MEDICAL CORP.LTD. is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine INDRAPRASTHA MEDICAL CORP.LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. INDRAPRASTHA MEDICAL CORP.LTD. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of INDRAPRASTHA MEDICAL CORP.LTD..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 571.95.

The bearish price targets are: 489.70 > 456.10 > 452.00.

Know someone who trades $INDRAMEDCO? Share this with them.πŸ‘‡

INDRAPRASTHA MEDICAL CORP.LTD. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of INDRAPRASTHA MEDICAL CORP.LTD.. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

INDRAPRASTHA MEDICAL CORP.LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of INDRAPRASTHA MEDICAL CORP.LTD.. The current macd is 22.05.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the INDRAPRASTHA MEDICAL CORP.LTD. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for INDRAPRASTHA MEDICAL CORP.LTD.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the INDRAPRASTHA MEDICAL CORP.LTD. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
INDRAPRASTHA MEDICAL CORP.LTD. Daily Moving Average Convergence/Divergence (MACD) ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of INDRAPRASTHA MEDICAL CORP.LTD.. The current adx is 37.35.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy INDRAPRASTHA MEDICAL CORP.LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
INDRAPRASTHA MEDICAL CORP.LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of INDRAPRASTHA MEDICAL CORP.LTD.. The current sar is 465.34.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
INDRAPRASTHA MEDICAL CORP.LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of INDRAPRASTHA MEDICAL CORP.LTD.. The current rsi is 64.28. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
INDRAPRASTHA MEDICAL CORP.LTD. Daily Relative Strength Index (RSI) ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of INDRAPRASTHA MEDICAL CORP.LTD.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the INDRAPRASTHA MEDICAL CORP.LTD. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
INDRAPRASTHA MEDICAL CORP.LTD. Daily Stochastic Oscillator ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of INDRAPRASTHA MEDICAL CORP.LTD.. The current cci is 57.72.

INDRAPRASTHA MEDICAL CORP.LTD. Daily Commodity Channel Index (CCI) ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of INDRAPRASTHA MEDICAL CORP.LTD.. The current cmo is 27.57.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
INDRAPRASTHA MEDICAL CORP.LTD. Daily Chande Momentum Oscillator (CMO) ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of INDRAPRASTHA MEDICAL CORP.LTD.. The current willr is -27.00438771.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that INDRAPRASTHA MEDICAL CORP.LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
INDRAPRASTHA MEDICAL CORP.LTD. Daily Williams %R ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of INDRAPRASTHA MEDICAL CORP.LTD..

INDRAPRASTHA MEDICAL CORP.LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of INDRAPRASTHA MEDICAL CORP.LTD.. The current atr is 18.32.

INDRAPRASTHA MEDICAL CORP.LTD. Daily Average True Range (ATR) ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of INDRAPRASTHA MEDICAL CORP.LTD.. The current obv is 5,376,404.

INDRAPRASTHA MEDICAL CORP.LTD. Daily On-Balance Volume (OBV) ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of INDRAPRASTHA MEDICAL CORP.LTD.. The current mfi is 76.40.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
INDRAPRASTHA MEDICAL CORP.LTD. Daily Money Flow Index (MFI) ChartINDRAPRASTHA MEDICAL CORP.LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for INDRAPRASTHA MEDICAL CORP.LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

INDRAPRASTHA MEDICAL CORP.LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of INDRAPRASTHA MEDICAL CORP.LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.275
Ma 20Greater thanMa 50450.665
Ma 50Greater thanMa 100431.738
Ma 100Greater thanMa 200408.109
OpenGreater thanClose494.750
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of INDRAPRASTHA MEDICAL CORP.LTD. with someone you think should read this too:
  • Are you bullish or bearish on INDRAPRASTHA MEDICAL CORP.LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about INDRAPRASTHA MEDICAL CORP.LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about INDRAPRASTHA MEDICAL CORP.LTD.

I send you an email if I find something interesting about INDRAPRASTHA MEDICAL CORP.LTD..


Comments

How you think about this?

Leave a comment

Stay informed about INDRAPRASTHA MEDICAL CORP.LTD..

Receive notifications about INDRAPRASTHA MEDICAL CORP.LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.